Pricing Log in Create free account

Dermata Therapeutics, Inc. (DRMA) vs Xenetic Biosciences, Inc. (XBIO)

Dermata Therapeutics, Inc. and Xenetic Biosciences, Inc. are both Biotechnology companies. Dermata Therapeutics, Inc. and Xenetic Biosciences, Inc. are of similar size ($4.7M and $4.5M). Dermata Therapeutics, Inc. has the higher net margin (0.00% vs −75.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Dermata Therapeutics, Inc. leads on 6 and Xenetic Biosciences, Inc. on 6.

Valuation

Metric DRMA XBIO Biotechnology median
P/E n/m n/m 8.50
P/S n/m 1.39 9.71
P/B 0.99 0.75 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.03 0.30 0.64
EV/Sales n/m (0.24) 9.21
Earnings yield (510.47%) (58.59%) (33.15%)
Free cash flow yield (232.27%) (50.87%) (25.50%)

Profitability

Metric DRMA XBIO Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (81.01%) 0.00%
Net margin 0.00% (75.90%) 0.00%
Free cash flow margin 0.00% (70.93%) 0.00%
Return on equity (183.89%) (47.05%) (56.36%)
Return on assets (139.93%) (40.17%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DRMA XBIO Biotechnology median
Revenue growth (TTM) — 33.30% 6.02%
EPS growth (last fiscal year) 89.84% 38.52% 30.26%
Revenue growth, 5-year CAGR — 46.78% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DRMA XBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.81 7.43 4.72
Net debt to EBITDA 0.97 2.78 0.96

Dividend

Metric DRMA XBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DRMA XBIO Biotechnology median
Market cap 4.51m 4.71m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack